40 Paul Tudor Jones II AMGEN Trades
Paul Tudor Jones II's position in AMGEN is currently worth $15.7 Million. That's 0.19% of their equity portfolio (124th largest holding). The first AMGEN trade was made in Q2 2013. Since then Paul Tudor Jones II bought shares 21 more times and sold shares on 22 occasions. The investor's estimated purchase price is $17.5 Million, resulting in a loss of 10%.
News about AMGEN Inc. and Paul Tudor Jones II
AstraZeneca: New Data Shows Tezspire''s Role In Future COPD Treatment
THOUSAND OAKS (dpa-AFX) - The primary results from the Phase IIa COURSE trial showed that treatment with AstraZeneca and Amgen''s Tezspire (tezepelumab) led ...
Understanding Biogen''s Position In Biotechnology Industry Compared To Competitors
In the dynamic and cutthroat world of business, conducting thorough company analysis is essential for investors and industry experts. In this article, we wil...
Top 5 2nd Quarter Trades of ABSHER WEALTH MANAGEMENT, LLC
Related Stocks: GOOGL , PII , AMGN , JNJ , RL ,
Amgen announces positive phase-II data for investigational Olpasiran in adults with elevated lipoprotein(a)
The study showed significant and sustained reduction in lipoprotein(a) during treatment period The post Amgen announces positive phase-II data for investigat...